本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kyverna Therapeutics

5.77
-0.4400-7.09%
盘后:5.820.0500+0.87%19:30 EDT
成交量:124.15万
成交额:730.18万
市值:3.57亿
市盈率:-2.00
高:6.17
开:6.17
低:5.76
收:6.21
52周最高:13.67
52周最低:5.76
股本:6,184.34万
流通股本:3,971.50万
量比:1.55
换手率:3.13%
股息:- -
股息率:- -
每股收益(TTM):-2.8809
每股收益(LYR):-3.6445
净资产收益率:-87.24%
总资产收益率:-44.51%
市净率:2.16
市盈率(LYR):-1.58

数据加载中...

2024/07/15

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/26

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/02/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/26

SEC问询函

Form CORRESP - Correspondence
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/16

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933